Cargando…

Acute respiratory failure on a low dose of amiodarone – is it an underdiagnosed and undertreated condition?

Amiodarone-induced pulmonary toxicity (AIPT) has a variety of presentations. Amiodarone use has been rarely associated with the development of acute respiratory failure. We present a patient with a history of paroxysmal atrial fibrillation who developed acute respiratory distress syndrome despite ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Meter, Mijo, Prusac, Ivana Kuzmić, Glavaš, Duška, Meter, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429964/
https://www.ncbi.nlm.nih.gov/pubmed/34527509
http://dx.doi.org/10.1016/j.rmcr.2021.101500
Descripción
Sumario:Amiodarone-induced pulmonary toxicity (AIPT) has a variety of presentations. Amiodarone use has been rarely associated with the development of acute respiratory failure. We present a patient with a history of paroxysmal atrial fibrillation who developed acute respiratory distress syndrome despite taking a low dose of amiodarone and having no risk or precipitating factors. The diagnosis of AIPT was made after drug discontinuation and exclusion of other potential causes. The development of acute respiratory failure due to AIPT is often underdiagnosed and undertreated. Better identification of risk factors and developing appropriate diagnostic tools for risk stratification of patients receiving amiodarone is mandatory.